Search Results - "Kros, J. M."

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide by DUBBINK, H. J, TAAL, W, BOOGERD, W, GROENENDIJK, F. H, SILLEVIS SMITT, PA. E, DINJENS, W. N. M, VAN DEN BENT, M. J, VAN MARION, R, KROS, J. M, VAN HEUVEL, I, BROMBERG, J. E, ZONNENBERG, B. A, ZONNENBERG, C. B. L, POSTMA, T. J, GIJTENBEEK, J. M. M

“…Mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) have been implicated in tumorigenesis of gliomas. Patients with high-grade astrocytomas with IDH1…”
Get full text

Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol by Bleeker, L., Kouwenhoven, M. C. M., de Heer, I., Lissenberg-Witte, B. I., Gijsbers, A. H., Dubbink, H. J., Kros, J. M., Gijtenbeek, J. M. M., Kurt, E., van der Rijt, C. C. D., Swaak-Kragten, A. T., de Vos, F. Y., van der Weide, H. L., French, P. J., van den Bent, M. J., Wesseling, P., Bromberg, J. E. C.

“…Purpose Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch…”
Get full text

Safety and efficacy of frameless and frame-based intracranial biopsy techniques by Dammers, R., Haitsma, I. K., Schouten, J. W., Kros, J. M., Avezaat, C. J. J., Vincent, A. J. P. E.

“…Summary Background. Frameless stereotaxy or neuronavigation has evolved into a feasible technology to acquire intracaranial biopsies with good accuracy and…”
Get full text

The complement system in glioblastoma multiforme by Bouwens van der Vlis, T A M, Kros, J M, Mustafa, D A M, van Wijck, R T A, Ackermans, L, van Hagen, P M, van der Spek, P J

“…The human complement system is represents the main effector arm of innate immunity and its ambivalent function in cancer has been subject of ongoing dispute…”
Get full text

Preoperative Normalization of Cortisol Levels in Cushing's Disease After Medical Treatment: Consequences for Somatostatin and Dopamine Receptor Subtype Expression and In Vitro Response to Somatostatin Analogs and Dopamine Agonists by van der Pas, R, Feelders, R. A, Gatto, F, de Bruin, C, Pereira, A. M, van Koetsveld, P. M, Sprij-Mooij, D. M, Waaijers, A. M, Dogan, F, Schulz, S, Kros, J. M, Lamberts, S. W. J, Hofland, L. J

“…Context: Corticotroph pituitary adenomas often highly express the dopamine 2 receptor (D2R) and somatostatin receptor subtype 5 (sst5). The sst2 expression is…”
Get full text

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 by VAN DEN BENT, M. J, TAPHOORN, M. J. B, ALLGEIER, A, GORLIA, T, BRANDES, A. A, MENTEN, J, STUPP, R, FRENAY, M, CHINOT, O, KROS, J. M, VAN DER RIJT, C. C. D, VECHT, Ch. J

“…Oligodendroglial tumors are chemotherapy-sensitive tumors, with two thirds of patients responding to combination chemotherapy with procarbazine, lomustine, and…”
Get full text

Tissue characterization using high wave number Raman spectroscopy by Koljenović, S, Bakker Schut, T C, Wolthuis, R, de Jong, B, Santos, L, Caspers, P J, Kros, J M, Puppels, G J

“…Raman spectroscopy is a powerful diagnostic tool, enabling tissue identification and classification. Mostly, the so-called fingerprint (approximately 400-1800…”
Get more information

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial by Gao, Y., Weenink, B., van den Bent, M.J., Erdem-Eraslan, L., Kros, J.M., Sillevis Smitt, PAE, Hoang-Xuan, K., Brandes, A.A., Vos, M., Dhermain, F., Enting, R., Ryan, G.F., Chinot, O., Ben Hassel, M., van Linde, M.E., Mason, W.P., Gijtenbeek, J.M.M., Balana, C., von Deimling, A., Gorlia, Th, Stupp, R., Hegi, M.E., Baumert, B.G., French, P.J.

“…The European Organisation for Research and Treatment of Cancer (EORTC) 22033-26033 clinical trial (NCT00182819) investigated whether initial temozolomide (TMZ)…”
Get full text

Medical applications of Raman spectroscopy: From proof of principle to clinical implementation by Choo-Smith, L.-P., Edwards, H. G. M., Endtz, H. P., Kros, J. M., Heule, F., Barr, H., Robinson Jr, J. S., Bruining, H. A., Puppels, G. J.

“…Raman spectroscopy has recently been applied ex vivo and in vivo to address various biomedical issues such as the early detection of cancers, monitoring of the…”
Get full text

Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomas by TRIEBELS, V. H. J. M, TAPHOORN, M. J. B, VAN HEUVEL, I, VAN DEN BENT, M. J, BRANDES, A. A, MENTEN, J, FRENAY, M, TOSONI, A, KROS, J. M, BIEMOND-TER STEGE, E, ENTING, R. H, ALLGEIER, A

“…The authors investigated the results of PCV chemotherapy within a cohort of 24 patients treated within the EORTC study 26971 on temozolomide chemotherapy in…”
Get full text

Raman Spectroscopic Characterization of Porcine Brain Tissue Using a Single Fiber-Optic Probe by Koljenović, S, Bakker Schut, T. C, Wolthuis, R, Vincent, A. J. P. E, Hendriks-Hagevi, G, Santos, L, Kros, J. M, Puppels, G. J

“…Accurate targeting of diseased and healthy tissue has significantly been improved by MRI/CT-based navigation systems. Recently, intraoperative MRI navigation…”
Get full text

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 by van den Bent, M. J., Chinot, O., Boogerd, W., Bravo Marques, J., Taphoorn, M. J. B., Kros, J. M., van der Rijt, C. C. D., Vecht, C. J., De Beule, N., Baron, B.

“…Background: Oligodendroglial tumors are chemosensitive, with two-thirds of patients responding to PCV combination chemotherapy with procarbazine, lomustine…”
Get full text

Filamin A mutation, a common cause for periventricular heterotopia, aneurysms and cardiac defects by de Wit, M C Y, Kros, J M, Halley, D J J, de Coo, I F M, Verdijk, R, Jacobs, B C, Mancini, G M S

“…Filamin A is an important gene involved in the development of the brain, heart, connective tissue and blood vessels. A case is presented illustrating the…”
Get full text

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery by van Veelen, M L C, Avezaat, C J J, Kros, J M, van Putten, W, Vecht, Ch

“…BACKGROUND A retrospective study of patients with low grade astrocytoma was carried out because the best management of such patients remains controversial…”
Get full text

From expert opinion to evidence-based: changes in the gold standard of primary brain tumour diagnosis by Kros, JM

“…Since 1997, significant progress has been made in the WHO guidelines for the diagnosis of primary tumours of the central nervous system. A large group of…”
Get full text

The CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma by Bralten, L B C, Gravendeel, A M, Kloosterhof, N K, Sacchetti, A, Vrijenhoek, T, Veltman, J A, van den Bent, M J, Kros, J M, Hoogenraad, C C, Sillevis Smitt, P A E, French, P J

“…Genomic translocations have been implicated in cancer. In this study, we performed a screen for genetic translocations in gliomas based on exon-level…”
Get full text

CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma by Zhu, C, Chrifi, I, Mustafa, D, van der Weiden, M, Leenen, P J M, Duncker, D J, Kros, J M, Cheng, C

“…Glioblastomas (glioblastoma multiforme, GBM) are most malignant brain tumors characterized by profound vascularization. The activation of macrophages strongly…”
Get full text

Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET : Case report of a primary spinal PNET occurrence with a critical literature review by KAMPMAN, W. A, KROS, J. M, DE JONG, T. H. R, LEQUIN, M. H

“…Intraspinal location of central PNET (cPNET) is very rare. We present a case, critically review all publications of primary intraspinal cPNET occurrence and…”
Get full text

Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families by Heutink, P, Stevens, M, Rizzu, P, Bakker, E, Kros, J M, Tibben, A, Niermeijer, M F, van Duijn, C M, Oostra, B A, van Swieten, J C

“…Hereditary frontotemporal dementia (HFTD) is a rare autosomal dominant form of presenile dementia characterized by behavioral changes and reduced speech. Three…”
Get more information

Temozolomide chemotherapy in recurrent oligodendroglioma by VAN DEN BENT, M. J, KEIME-GUIBERT, F, BRANDES, A. A, TAPHOORN, M. J. B, KROS, J. M, ESKENS, F. A. L. M, CARPENTIER, A. F

“…The authors determined the tolerance, response rate, and duration of recurrent anaplastic oligodendroglioma in 30 patients to temozolomide given orally at 150…”
Get full text